Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker.
Winkler T, Kohli P, Kelly VJ, Kehl EG, Witkin AS, Rodriguez-Lopez JM, Hibbert KA, Kone MT, Systrom DM, Waxman AB, Venegas JG, Channick RN, Harris RS.
Respir Res. 2022 Dec 1;23(1):325. doi: 10.1186/s12931-022-02239-8.